San Francisco, CA
United States
Parker Institute for Cancer Immunotherapy
tumor immunology, tumor heterogeneity, Immune checkpoint blockade, T cell costimulation, Neutrophils, innate immunity
LKB1, lung adenocarcinoma, PD-1, immunotherapy resistance, lactate, MCT4, T cell activation, macrophage polarization, metabolism